Current Controlled Trials - Search the ISRCTN Register of Clinical Trials.

Welcome

10 February 2012

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN Register

Registration

New application

Updating record

Information

introduction

governing board

ISRCTN FAQs

data set

guidance notes

International Standard Randomised Controlled Trial Number Register

Showing records: 5941 to 5950 of 10349

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS

5941	A multicentric, open, comparative, randomized, study to optimize dose, duration, safety, efficacy, and cost of two treatment regimens with liposomal amphotericin (Fungisome) in the treatment of systemic infection in India
	ISRCTN:	ISRCTN52812742
	Sponsor:	Government of India (India) - Department of Biotechnology
	Date assigned:	19 May 2006

5942	Cisplatin, capecitabine, and radiation therapy with or without cetuximab in treating patients with oesophageal cancer
	ISRCTN:	ISRCTN47718479
	Sponsor:	Velindre NHS Trust (UK)
	Date assigned:	18 May 2006

5943	Using genotype to tailor prescribing of Nicotine Replacement Therapy (NRT): a randomised controlled trial assessing impact upon medication adherence
	ISRCTN:	ISRCTN14352545
	Sponsor:	King's College London (UK)
	Date assigned:	17 May 2006

5944	Colposuspension or tension free vaginal tape with anterior repair for urinary incontinence and prolapse: a pilot study
	ISRCTN:	ISRCTN34759911
	Sponsor:	University Hospitals of Leicester NHS Trust (UK)
	Date assigned:	17 May 2006

5945	Usefulness of a three-step guideline to reduce length of hospital stay for patients with community-acquired pneumonia: a randomised controlled trial
	ISRCTN:	ISRCTN17875607
	Sponsor:	Spanish National Health Service (Fondo de Investigación Sanitaria)
	Date assigned:	17 May 2006

5946	Effect of Valsartan in Ventricular Function and Aortic Elasticity
	ISRCTN:	ISRCTN10318149
	Sponsor:	Beth Israel Deaconess Medical Centre (USA)
	Date assigned:	17 May 2006

5947	A phase II, randomised, double-blind, placebo-controlled pilot study of the safety, tolerability and activity of intramuscularly administered a-Epi-Br (HE2000) in late stage human immunodeficiency virus-infected patients at risk for opportunistic infections
	ISRCTN:	ISRCTN81525828
	Sponsor:	Hollis-Eden Pharmaceuticals, Inc. (USA)
	Date assigned:	15 May 2006

5948	A multicentre study using the chemotherapy combination of bi-monthly Xeloda and Eloxatin, with the addition of Avastin, in patients with advanced colorectal cancer
	ISRCTN:	ISRCTN41540878
	Sponsor:	Cancer Trials New Zealand (CTNZ)
	Date assigned:	15 May 2006

5949	Randomised double-blind, placebo-controlled trial of selenium supplementation in adult asthma
	ISRCTN:	ISRCTN31432640
	Sponsor:	Department of Health (UK)
	Date assigned:	15 May 2006

5950	Randomized phase III trial of paclitaxel plus topotecan versus topotecan plus cisplatin in recurrent or persistent cervical cancer stage IVb
	ISRCTN:	ISRCTN77165120
	Sponsor:	Institute for Women’s Health (Institut fuer Frauengesundheit GmbH) (Germany)
	Date assigned:	15 May 2006

RESULT PAGE

595


© 2012 ISRCTN unless otherwise stated.